Switzerland
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
4.88 |
Jan. 14, 2025 | USD 329.06 | 0.76% |
|
Switzerland |
|
2 |
4.23 |
Jan. 14, 2025 | USD 119.40 | 0.87% |
|
Switzerland |
|
3 |
3.96 |
Jan. 14, 2025 | USD 73.39 | 4.71% |
|
Switzerland |
|
4 |
2.46 |
Jan. 14, 2025 | USD 244.50 | 0.95% |
|
Switzerland |
|
5 |
2.26 |
Jan. 14, 2025 | USD 165.41 | 0.50% |
|
Switzerland |
|
6 |
1.17 |
Jan. 14, 2025 | USD 56.52 | -0.28% |
|
Switzerland |
|
7 |
0.78 |
Jan. 14, 2025 | USD 11.09 | -3.14% |
|
Switzerland |
The Medical Instruments company in Switzerland with the highest Price to Sales Ratio (P/S) is Sonova Holding AG (Swiss Stock Exchange: SOON.SW) at 4.88.
The Medical Instruments company in Switzerland with the lowest Price to Sales Ratio (P/S) is medmix AG (Swiss Stock Exchange: MEDX.SW) at 0.78.
The top 10 Medical Instruments companies in Switzerland by Price to Sales Ratio (P/S) are Sonova Holding AG, Medacta Group SA, Medartis Holding AG, Tecan Group AG, IVF Hartmann Holding AG, COLTENE Holding AG and medmix AG.
The bottom 10 Medical Instruments companies in Switzerland by Price to Sales Ratio (P/S) are medmix AG, COLTENE Holding AG, IVF Hartmann Holding AG, Tecan Group AG, Medartis Holding AG, Medacta Group SA and Sonova Holding AG.